statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sun Pharma Completes Taro Merger

Sun Pharma Completes Taro Merger Sun Pharma Completes Taro Merger PR Newswire MUMBAI, India and PRINCETON, N.J., June 24, 2024 Combined entity is better positioned to compete in increasingly...

Taro Shareholders Approve Merger with Sun Pharma

Taro Shareholders Approve Merger with Sun Pharma Taro Shareholders Approve Merger with Sun Pharma PR Newswire MUMBAI, India and NEW YORK, May 23, 2024 MUMBAI, India and NEW YORK, May 23, 2024...

Taro Provides Results for Year Ended March 31, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024...

Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.

Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun...

Taro to Release Full Year Results on May 20, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2024, after the close of market on Monday, May 20, 2024. The...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote FOR Taro Sun Pharma Merger

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today announced that leading independent proxy advisory firms Institutional Shareholder Services (ISS) and Glass Lewis & Co...

TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Taro Pharmaceutical Industries Ltd. (NYSE...

Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today announced that it has called an extraordinary general meeting of its shareholders (the Extraordinary General Meeting), to...

Taro Pharmaceutical Industries (NYSE:TARO) Earns Strong-Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a research report sent to investors on Wednesday morning. The firm issued a strong-buy rating...

Taro Pharmaceutical Industries (NYSE:TARO) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a strong-buy...

Established in 1950, Taro Pharmaceutical Industries Ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. Taro’s research programs and niche strategy have enabled the Company to achieve gross margins that are among the highest in the specialty pharmaceutical sector.

Volume	13,011.00
52-Wk High	$45.76
52-Wk Low	$32.67

TARO Taro Pharmaceutical Industries

About

Feed

News

Earnings

Fundamentals